Tissue polypeptide specific antigen in the post therapeutic evaluation of patients with ovarian and colorectal cancer

Sharmila Upadhya; Subramanya Upadhya; D. M. Vasudevan

首页> 外文期刊>Indian journal of clinical biochemistry >Tissue polypeptide specific antigen in the post therapeutic evaluation of patients with ovarian and colorectal cancer

【24h】

Tissue polypeptide specific antigen in the post therapeutic evaluation of patients with ovarian and colorectal cancer

机译：组织多肽特异性抗原在卵巢癌和大肠癌患者治疗后评估中的作用

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The study was designed to evaluate the significance of tissue polypeptide specific antigen (TPS) in patients with histologically proven ovarian and colorectal cancer following treatment along with CA125 (in ovarian cancer) and CEA (in colorectal cancer). Patients were grouped as follows:

机译：这项研究旨在评估组织多肽特异性抗原（TPS）在组织学上证实为卵巢癌和结肠直肠癌以及CA125（卵巢癌）和CEA（结肠直肠癌）治疗后的意义。患者分为以下几类：

著录项

来源
《Indian journal of clinical biochemistry》 |2003年第1期|共页
作者
Sharmila Upadhya; Subramanya Upadhya; D. M. Vasudevan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer [J] . M Carpelan-Holmstr?m, C Haglund, J Lundin, British Journal of Cancer . 1996,第6期

机译：术前血清标志物CA 242，特定组织多肽抗原和人绒毛膜促性腺激素β的独立预后价值，但对大肠癌的癌胚抗原或组织多肽抗原没有独立的预后价值
2. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer [J] . M Carpelan-Holmstr?m, C Haglund, J Lundin, British Journal of Cancer . 1996,第6期

机译：术前血清标志物CA 242，特定组织多肽抗原和人绒毛膜促性腺激素β的独立预后价值，但对大肠癌的癌胚抗原或组织多肽抗原没有独立的预后价值
3. The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study [J] . Fiala Ondrej, Finek Jindrich, Buchler Tomas, Targeted oncology . 2015,第4期

机译：贝伐单抗治疗转移性结直肠癌患者的血清癌胚抗原，糖抗原19-9，胸苷激酶和组织多肽特异性抗原与结局的关系：一项回顾性研究
4. Quantitative In Vivo Ex Vivo Multimodality Cell Imaging of Antigen-Specific T-CeIIs in Murine Metastatic Ovarian Cancer [C] . WilladsenM., YarovoyI., ParashuramaN. Bioengineering and Translational Medicine Conference . 2018

机译：鼠转移卵巢癌中抗原特异性T-CeIIS的体内和离体多层细胞成像的定量
5. Identifying Potential Therapeutic Compounds for Patient Specific Models of Colorectal Cancer Using Drosophila [D] . Arroyo, Daniel. 2020

机译：使用果蝇鉴定患者特异性癌症患者特异性模型的潜在治疗化合物
6. Tissue polypeptide specific antigen in the post therapeutic evaluation of patients with ovarian and colorectal cancer [O] . Sharmila Upadhya, Subramanya Upadhya, D. M. Vasudevan 2003

机译：组织多肽特异性抗原在卵巢癌和大肠癌患者治疗后评估中的作用
7. TISSUE POLYPEPTIDE SPECIFIC ANTIGEN IN THE POST THERAPEUTIC EVALUATION OF PATIENTS WITH OVARIAN AND COLORECTAL CANCER [O] . Sharmila Upadhya, Subramanya Upadhya, D. M. Vasudevan 2015

机译：卵巢癌和大肠癌患者术后治疗中的组织多肽特异性抗原
8. Pathogenesis of Ovarian Serous Carcinoma as the Basis for Immunologic Directed Diagnosis and Treatment. Project 3 - Development of Antigen-Specific Cancer Vaccines for the Control of Ovarian Cancer [R] . Kurman, R. J. , Wu, T. C. 2003

机译：卵巢浆液性癌的发病机制作为免疫定向诊断和治疗的基础。项目3-开发用于控制卵巢癌的抗原特异性癌症疫苗

Tissue polypeptide specific antigen in the post therapeutic evaluation of patients with ovarian and colorectal cancer

摘要

著录项

相似文献

相关主题

期刊订阅